EP Patent

EP2596826A1 — Safety syringe

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2013-05-29 · 13y expired

What this patent protects

Described is a syringe (3) comprising a barrel, a stopper (5) slidably arranged within the barrel, a needle (4) arranged on a distal end of the barrel, a plunger coupling (10) coupled to the stopper (5) and adapted to releasably engage a plunger (11), and a needle retraction mech…

USPTO Abstract

Described is a syringe (3) comprising a barrel, a stopper (5) slidably arranged within the barrel, a needle (4) arranged on a distal end of the barrel, a plunger coupling (10) coupled to the stopper (5) and adapted to releasably engage a plunger (11), and a needle retraction mechanism adapted to retract the needle (4) into the barrel.

Drugs covered by this patent

Patent Metadata

Patent number
EP2596826A1
Jurisdiction
EP
Classification
Expires
2013-05-29
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.